Ara
Toplam kayıt 36, listelenen: 21-30
Assessment of the Gail model in estimating the risk of breast cancer: Effect of cancer worry and risk in healthy women
(Asian Pacific Organization for Cancer Prevention, 2019)
Background: There has been substantial interest in developing methods to predict the risk of breast cancer. The Gail model is one the first model have been widely used to identify women at higher risk of breast cancer. ...
An examination of health care utilization during the COVID-19 pandemic among women with early-stage hormone receptor-positive breast cancer
(BioMed Central Ltd, 2022)
Background: Women undergoing treatment for breast cancer require frequent clinic visits for maintenance of therapy. With COVID-19 causing health care disruptions, it is important to learn about how this population’s access ...
Chemopreventive effects of hydatid disease on experimental breast cancer
(Asian Pacific Organization for Cancer Prevention, 2015)
Breast cancer is one of the most common and letal cancers in all over the world. Since there have been significant improvements in treatment of breast cancer, there is still a big need for alternative approaches. In this ...
Important factors affecting adjuvant treatment decision in stage IA breast cancer patients in Turkey
(S. Karger AG, 2014)
Introduction: In Turkey, the gene expression profile test is not standard, so adjuvant treatment is planned according to clinicopathological factors. Therefore, we retrospectively analyzed important parameters that affect ...
Identification of ApoA1, HPX and POTEE genes by omic analysis in breast cancer
(Spandidos Publications, 2014)
Breast cancer is the most common cancer among women and accounts for 23% of all female types of cancers. It is well recognized that breast cancer represents a heterogeneous group of tumors, and the molecular events involved ...
Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer
(Zerbinis Medical Publications, 2014)
Purpose: The aim of this study was to compare the hormone receptors' (HR) and HER2/neu status between core needle biopsy (CNB) and residual tumor after surgery of breast cancer treated with neoadjuvant chemotherapy (NAC), ...
Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society
(Elsevier Ireland Ltd, 2022)
This care pathway from the European Menopause and Andropause Society (EMAS) provides an updated pathway for monitoring and guidance of women at midlife, focusing on those approaching the end of the reproductive lifecycle, ...
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)
(BMC, 2023)
Following publication of the original article [1], the authors reported an error in the author name of Enes Erul.
Effects of chitosan nanoparticles with long synthetic siRNAs targeting VEGF in triple-negative breast cancer cells
(Faculdade de Ciencias Farmaceuticas (Biblioteca), 2023)
Vascular endothelial growth factor (VEGF) is an essential angiogenic factor in breast cancer development and metastasis. Small interfering RNAs (siRNAs) can specifically silence genes via the RNA interference pathway, ...
Evaluation of knowledge and practice regarding mammography among a group of Turkish women attending a tertiary hospital
(Turkish Surgical Association, 2022)
Objective: Early detection is the most important cornerstone of breast cancer in determining treatment outcome and survival. In this study, it was aimed to investigate the level of knowledge, attitude, and practice of ...